IMPLEMENTATION OF AN EDUCATION INTERVENTION FOR MULTIPLE MYELOMA PATIENTS RECEIVING STEM CELL TRANSPLANT

被引：0
|
作者：
Halpin, Sean [1 ]
Konomos, Michael [2 ]
机构：
[1] Evidera, Decatur, GA USA
[2] Emory Univ, Atlanta, GA 30322 USA
来源：
INNOVATION IN AGING | 2022年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：235 / 235
页数：1
相关论文
共 50 条
  • [21] Outcome of Patients with Multiple Myeloma by Ethnicity in the Setting of Autologous Stem Cell Transplant
    Sasaki, Koji
    Bashir, Qaiser
    Shah, Nina
    Hosing, Chitra
    Popat, Uday R.
    Nieto, Yago
    Parmar, Simrit
    Shah, Jatin
    Weber, Donna
    Thomas, Sheeba
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S231 - S232
  • [22] Outcomes after Autologous Stem Cell Transplant in Patients with Relapsed Multiple Myeloma
    Lemieux, Christopher
    Craig, Juliana
    Iberri, David
    Arai, Sally
    Johnston, Laura J.
    Lowsky, Robert
    Muffly, Lori S.
    Shiraz, Parveen
    Liedtke, Michaela
    Rezvani, Andrew R.
    Frank, Matthew J.
    Weng, Wen-Kai
    Meyer, Everett H.
    Shizuru, Judith A.
    Negrin, Robert S.
    Miklos, David B.
    Sidana, Surbhi
    BLOOD, 2020, 136
  • [23] Autologous stem cell transplant for multiple myeloma patients 70 years or older
    E Muchtar
    D Dingli
    S Kumar
    F K Buadi
    A Dispenzieri
    S R Hayman
    R C Wolf
    D A Gastineau
    R Chakraborty
    W J Hogan
    N Leung
    P Kapoor
    M Q Lacy
    S V Rajkumar
    M A Gertz
    Bone Marrow Transplantation, 2016, 51 : 1449 - 1455
  • [24] Autologous stem cell transplant for multiple myeloma patients 70 years or older
    Muchtar, E.
    Dingli, D.
    Kumar, S.
    Buadi, F. K.
    Dispenzieri, A.
    Hayman, S. R.
    Wolf, R. C.
    Gastineau, D. A.
    Chakraborty, R.
    Hogan, W. J.
    Leung, N.
    Kapoor, P.
    Lacy, M. Q.
    Rajkumar, S. V.
    Gertz, M. A.
    BONE MARROW TRANSPLANTATION, 2016, 51 (11) : 1449 - 1455
  • [25] Fludarabine/cyclophosphamide conditioning for allogeneic stem cell transplant in patients with multiple myeloma
    Morabito, F
    Martino, M
    Mandaglio, R
    Penna, G
    Cuzzola, M
    Cuzzocrea, A
    Pucci, G
    Console, G
    Irrera, G
    Iacopino, O
    Messina, G
    Iacopino, P
    BONE MARROW TRANSPLANTATION, 2003, 31 : S157 - S157
  • [26] RESULTS OF AUTOLOGOUS STEM CELL TRANSPLANT IN MULTIPLE MYELOMA PATIENTS WITH RENAL FAILURE
    Ben Abdeljelil, N.
    Torjemane, L.
    Lakhal, A.
    Elfatmi, R.
    Ladeb, S.
    Ben Othman, T.
    HAEMATOLOGICA, 2014, 99 : 656 - 656
  • [27] PARP1 EXPRESSION IS A STRONG PROGNOSTIC BIOMARKER IN MULTIPLE MYELOMA PATIENTS RECEIVING AUTOLOGOUS STEM CELL TRANSPLANT.
    Thomas, M.
    King, K.
    Seligson, N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S52 - S52
  • [28] Duration of frontline therapy and impact on clinical outcomes in newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant
    Ailawadhi, Sikander
    Ogbonnaya, Augustina
    Murty, Sharanya
    Cherepanov, Dasha
    Schroader, Bridgette Kanz
    Romanus, Dorothy
    Farrelly, Eileen
    Chari, Ajai
    CANCER MEDICINE, 2023, 12 (03): : 3145 - 3159
  • [29] Safety of therapeutic anticoagulation in patients with multiple myeloma receiving autologous stem cell transplantation
    AD Schimmer
    AK Stewart
    A Keating
    J MacKinnon
    M Crump
    DM Sutton
    FA Shepherd
    J Meharchand
    Bone Marrow Transplantation, 1998, 22 : 491 - 494
  • [30] Safety of therapeutic anticoagulation in patients with multiple myeloma receiving autologous stem cell transplantation
    Schimmer, AD
    Stewart, AK
    Keating, A
    MacKinnon, J
    Crump, M
    Sutton, DM
    Shepherd, FA
    Meharchand, J
    BONE MARROW TRANSPLANTATION, 1998, 22 (05) : 491 - 494
12345